NeuroPace Inc
NPCEHealthcare·Medical Devices·USA·Micro·NASD·Nov 13 • 7:00 AM ET
7.72-4.30 (-35.77%)
2026-11-13 13:03 CET
Market cap
$264.98M
Revenue, TTM
94.59 USD m
Net income, TTM
-18.92 USD m
Free cash flow, TTM
-12.41 USD m
EPS diluted, TTM
-0.56
Price
NPCE against its 20, 50 and 200-day averagesPatternshover a marker to name it
60.6% under the 52-week high of 19.60 on 8 May 2026. 52-week low 7.55 on 13 Nov 2026. Last 15 sessions, 84.6% high to low
Volume 2.97× normal · the line is the 50-bar volume average
Setup. RS line 35
CANSLIM 1 of 6 — fails: EPS Growth Qtr Over Qtr: High (>25%); EPS Growth This Year: High (>25%); 52-Week High/Low: 0-10% below High; Performance: Year +50%; Average Volume: Over 200K
VCP 2 of 6 — fails: 200-Day Simple Moving Average: Price above SMA200; 50-Day Simple Moving Average: SMA50 above SMA200; 52-Week High/Low: 0-10% below High; Relative Volume: Under 1
Minervini 0 of 4 — fails: 200-Day Simple Moving Average: Price above SMA200; 50-Day Simple Moving Average: SMA50 above SMA200; 52-Week High/Low: 0-10% below High; Performance: Year +50%
Zanger 1 of 5 — fails: RSI (14): Not Oversold (>50); Performance: Week +10%; 20-Day High/Low: 0-5% below High; 200-Day Simple Moving Average: Price above SMA200
Leaders 0 of 5 — fails: 50-Day Simple Moving Average: Price above SMA50; 200-Day Simple Moving Average: Price above SMA200; Performance: Year +50%; Average Volume: Over 500K; 52-Week High/Low: 0-10% below High
Breakout 1 of 4 — fails: 52-Week High/Low: New High; 50-Day Simple Moving Average: Price above SMA50; 200-Day Simple Moving Average: Price above SMA200
Growth 1 of 4 — fails: EPS Growth Qtr Over Qtr: High (>25%); EPS Growth This Year: High (>25%); Return on Equity: Over +15%
Quality 1 of 5 — fails: Return on Equity: Over +15%; Net Profit Margin: High (>20%); Debt/Equity: Low (<0.1) — not on the tape: P/E: Under 25
Value 0 of 4 — fails: P/B: Under 2; Return on Equity: Over +15%; Debt/Equity: Low (<0.1) — not on the tape: P/E: Under 15
Income 0 of 4 — fails: Dividend Growth: Growing 2+ Years — not on the tape: Dividend Yield: Over 2%; Payout Ratio: Low (<20%); P/E: Under 25
Small Cap 1 of 4 — fails: Average Volume: Over 500K; 200-Day Simple Moving Average: Price above SMA200; Performance: Year +50%
Accumulation 1 of 4 — fails: Institutional Transactions: Over +10%; 200-Day Simple Moving Average: Price above SMA200; Performance: Year Up
Relative Strength 0 of 3 — fails: Performance: Year +100%; 200-Day Simple Moving Average: Price above SMA200; Average Volume: Over 500K
Profile
NPCE52-week range, 1% of the way up
7.5519.60
NeuroPace, Inc. develops, manufactures, and markets implantable devices for treating epilepsy and neurological disorders. It offers implantable components, which include the RNS neurostimulator as well as depth and cortical strip leads. The firm's RNS System is designed for the treatment of medically refractory partial epilepsy and includes implantable and external products. The company was founded by Rebecca L. Kuhn, Frank M. Fischer on November 19, 1997 and is headquartered in Mountain View, CA.
| Index | RUT |
|---|---|
| Employees | 209 |
| IPO | Apr 22, 2021 |
| Beta | 1.94 |
| ATR, 14d | 0.96 |
| Rel volume | 2.97 |
| Short float | 3.20% |
| Insider own | 21.91% |
| Inst own | 75.03% |
Snapshot
6 groupsValuation
| Index | RUT |
|---|---|
| Market Cap | $264.98M |
| Enterprise Value | 285.29M |
| Income | -18.92M |
| Sales | 94.59M |
| Book / share | 0.35 |
| Cash / share | 1.43 |
| Dividend Est. | - |
| Dividend TTM | - |
| Dividend Ex-Date | - |
| Dividend Gr. 3/5Y | - - |
| Payout | - |
| Employees | 209 |
| IPO | Apr 22, 2021 |
Ratios
| Price / earnings | - |
|---|---|
| Forward price / earnings | - |
| Price / earnings / growth | - |
| Price / sales | 2.80 |
| Price / book | 22.27 |
| Price / cash | 5.38 |
| Price / free cash flow | - |
| Value / cash profit | - |
| Value / sales | 3.02 |
| Quick Ratio | 4.09 |
| Current Ratio | 5.26 |
| Debt / equity | 6.05 |
| Long-term debt / equity | 5.85 |
| Options and short | Yes / Yes |
Earnings
| Earnings / share | -0.56 |
|---|---|
| Earnings next year | -0.28 |
| Earnings next quarter | -0.12 |
| Earnings this year | 15.15% |
| Earnings next year | 50.89% |
| Earnings growth, 5 years | 44.68% |
| Past earnings growth | 30.02% 8.43% |
| Past sales growth | 29.99% 19.44% |
| Earnings vs last year | 31.90% |
| Sales vs last year | -0.29% |
| Earnings vs last quarter | 9.00% |
| Sales vs last quarter | -15.54% |
| Earnings | Nov 12 AMC |
| Surprise | 8.09% -14.82% |
Ownership
| Insiders own | 21.91% |
|---|---|
| Insider trades | 0.00% |
| Institutions own | 75.03% |
| Institution trades | 3.09% |
| Return on assets | -18.73% |
| Return on equity | -126.06% |
| Return on capital | -24.03% |
| Gross Margin | 83.07% |
| Operating margin | -15.39% |
| Profit Margin | -20.00% |
| 20-day average | -38.46% |
| 50-day average | -41.56% |
| 200-day average | -47.71% |
Technical
| Shares out | 34.32M |
|---|---|
| Shares floating | 26.80M |
| Short / float | 3.20% |
| Short ratio | 6.66 |
| Short interest | 0.86M |
| 52-week high | 19.60 -60.6% |
| 52-week low | 7.55 +2.3% |
| Volatility | 5.66% 5.14% |
| Average range | 0.96 |
| Strength index | 21.09 |
| Market sensitivity | 1.94 |
| Relative volume | 2.97 |
| Avg Volume | 128.95K |
| Volume | 19,145 |
Performance
| Perf Week | -38.24% |
|---|---|
| Perf Month | -39.59% |
| Perf Quarter | -45.94% |
| Perf Half Y | -49.74% |
| Perf YTD | -50.00% |
| Perf Year | -39.73% |
| Perf 3Y | -9.07% |
| Perf 5Y | -44.86% |
| Perf 10Y | - |
| Recommendation | 1.00 |
| Target Price | 19.33 |
| Prev Close | 12.02 |
| Price | 7.72 |
| Change % | -35.77% |
Analyst ratings
latest 10 of 19| Date | Action | Analyst | Rating change | Target | Implied |
|---|---|---|---|---|---|
| Today | Downgrade | Leerink | Outperform → Market Perform | $7 | -9.3% |
| Sep 18, 2026 | Initiated | KeyBanc Capital Markets | Overweight | $18 | +133.2% |
| Jul 23, 2026 | Initiated | Mizuho | Outperform | $22 | +185.0% |
| May 28, 2025 | Initiated | H.C. Wainwright | Buy | $18 | +133.2% |
| Jan 21, 2025 | Initiated | UBS | Buy | $17 | +120.2% |
| Mar 14, 2024 | Upgrade | Wells Fargo | Equal Weight → Overweight | $16 → $20 | +159.1% |
| Jan 30, 2024 | Initiated | Leerink Partners | Outperform | $22 | +185.0% |
| Nov 10, 2023 | Initiated | Cantor Fitzgerald | Overweight | $11 | +42.5% |
| Aug 24, 2023 | Upgrade | Morgan Stanley | Underweight → Equal-Weight | $5 → $6 | -22.3% |
| Feb 22, 2023 | Initiated | Lake Street | Buy | $10 | +29.5% |
Peers
Mkt capInsider trading
2 filings| Insider | Relationship | Date | Transaction | Cost | Shares | Value | Total held | Form |
|---|---|---|---|---|---|---|---|---|
| Morrell Martha | CHIEF MEDICAL OFFICER | Dec 15 '25 | Sale | 15.97 | 25,000 | 399,250 | 49,964 | Mar 04 04:43 PM |
| MARTHA J MORRELL | Officer | Dec 15 '25 | Proposed Sale | 16.19 | 25,000 | 404,750 | Dec 15 04:26 PM |
Held by
AUM| Ticker | Company | AUM |
|---|---|---|
| VTI | Vanguard Morningstar Total Stock Market ETF | AUM: 696.31B |
| IWM | iShares Russell 2000 Index Fund | AUM: 77.86B |
| VXF | Vanguard Extended Market Index ETF | AUM: 30.79B |
| IWO | iShares Russell 2000 Growth ETF | AUM: 14.25B |
| VTWO | Vanguard Russell 2000 Index ETF | AUM: 16.90B |
| IWC | iShares Micro-Cap ETF | AUM: 1.23B |
| XHE | State Street SPDR S&P Health Care Equipment ETF | AUM: 162.56M |
| VTWG | Vanguard Russell 2000 Growth Index ETF | AUM: 1.43B |
| GSSC | Goldman Sachs ActiveBeta U.S. Small Cap Equity ETF | AUM: 1.07B |
| RSSL | Global X Russell 2000 ETF | AUM: 1.44B |
News
latest 14 of 200- NeuroPace Stalls: RNS Growth Collapses To 1% And A Deep Guidance Cut Overshadows Record Margins (Earnings Whispers) -35.77%
- NeuroPace Inc.: Q3 Earnings Snapshot (Associated Press)
- NeuroPace Reports Third Quarter 2026 Financial Results and Provides Revised Full Year Guidance (Business Wire)
- NeuroPace Must Show Core RNS Strength Can Carry The Story While IGE Approval Stalls (Earnings Whispers) +8.37%
- NeuroPace to Report Third Quarter 2026 Financial Results on November 12, 2026 (Business Wire) -5.46%
- NeuroPace to Participate in 2026 Cantor Global Healthcare Conference (Business Wire)
- NeuroPace to Participate in Wells Fargo 21st Annual Healthcare Conference (Business Wire)
- NeuroPace Inc (NPCE) (Q2 2026) Earnings Call Highlights: Strong RNS Growth and AI Launch Offset ... (GuruFocus.com)
- NeuroPace Inc.: Q2 Earnings Snapshot (Associated Press)
- NeuroPace Reports Second Quarter 2026 Financial Results and Raises 2026 Revenue Guidance (Business Wire)
- NeuroPace Receives FDA Guidance on PMA Supplement for Indication Expansion into Idiopathic Generalized Epilepsy (Business Wire) -10.91%
- NeuroPace to Highlight Expanding Role of Responsive Neuromodulation at the 2026 American Society for Stereotactic and Functional Neurosurgery (ASSFN) Meeting (Business Wire)
- NeuroPace Announces FDA Approval of ECoG Assistant, Advancing AI-Driven Epilepsy Care (Business Wire)
- NPCE Explains How NeuroPace's RNS System Makes Money (Quartz)
Quarterly earnings
2026Q3 EPS -0.100 beat -0.109, from -0.110 a year earlier. Sales 23.10 missed 27.13, from 27.35 a year earlier
The outline behind the bar is the estimate. The filled bar is the print. Green beat it, red missed it.
| Period | Reported | EPS adjusted | EPS est | EPS reported | Sales act, USD m | Sales est, USD m | Surprise | Year-ago quarter | Analysts | Next session |
|---|---|---|---|---|---|---|---|---|---|---|
| 2026Q3ended 2026-09-30 | 2026-11-12 16:30 | -0.100 | -0.109 | -0.096 | 23.10 | 27.13 | EPS -8.1% · sales -14.8% | vs 2025Q3, year-ago quarter · EPS -9.1% · sales -15.5% | 8 EPS · 9 sales | Open -29.56% vs SPY -0.14%. Close -35.77% vs SPY +0.32% |
| 2026Q2ended 2026-06-30 | 2026-08-11 16:30 | -0.180 | -0.218 | -0.182 | 22.83 | 22.61 | EPS -17.4% · sales +0.9% | vs 2025Q2, year-ago quarter · EPS -30.8% · sales -3.0% | 7 EPS · 9 sales | Open -5.91% vs SPY +0.54%. Close -3.26% vs SPY +0.25% |
| 2026Q1ended 2026-03-31 | 2026-05-12 16:30 | -0.200 | -0.230 | -0.198 | 22.00 | 21.65 | EPS -13.0% · sales +1.6% | vs 2025Q1, year-ago quarter · EPS -4.8% · sales -2.3% | 8 | Open -6.14% vs SPY +0.04%. Close +0.06% vs SPY +0.56% |
| 2025Q4ended 2025-12-31 | 2026-03-03 16:30 | -0.080 | -0.156 | -0.082 | 26.59 | 24.75 | EPS -48.8% · sales +7.4% | vs 2024Q4, year-ago quarter · EPS -55.6% · sales +23.9% | 8 | Open +12.73% vs SPY +0.19%. Close +0.87% vs SPY +0.71% |
| 2025Q3ended 2025-09-30 | 2025-11-04 16:30 | -0.110 | -0.195 | -0.106 | 27.35 | 24.64 | EPS -43.7% · sales +11.0% | vs 2024Q3, year-ago quarter · EPS -42.1% · sales +29.9% | 7 EPS · 8 sales | Open +23.72% vs SPY -0.04%. Close +38.09% vs SPY +0.35% |
| 2025Q2ended 2025-06-30 | 2025-08-12 16:30 | -0.260 | -0.223 | -0.263 | 23.52 | 23.09 | EPS +16.6% · sales +1.9% | vs 2024Q2, year-ago quarter · EPS 0.0% · sales +22.1% | 8 | Open -1.97% vs SPY +0.35%. Close +2.08% vs SPY +0.34% |
| 2025Q1ended 2025-03-31 | 2025-05-13 16:30 | -0.210 | -0.241 | -0.209 | 22.52 | 21.88 | EPS -12.8% · sales +2.9% | vs 2024Q1, year-ago quarter · EPS -34.4% · sales +24.3% | 7 | Open +10.42% vs SPY +0.17%. Close +20.46% vs SPY +0.13% |
| 2024Q4ended 2024-12-31 | 2025-03-04 16:30 | -0.180 | -0.223 | -0.176 | 21.47 | 21.14 | EPS -19.2% · sales +1.6% | vs 2023Q4, year-ago quarter · EPS -21.7% · sales +19.2% | 7 | Open +6.12% vs SPY -0.03%. Close -2.43% vs SPY +1.07% |
| 2024Q3ended 2024-09-30 | 2024-11-12 16:30 | -0.190 | -0.269 | -0.185 | 21.06 | 19.07 | EPS -29.3% · sales +10.4% | vs 2023Q3, year-ago quarter · EPS -32.1% · sales +28.2% | 7 EPS · 6 sales | Open +8.12% vs SPY +0.08%. Close +28.15% vs SPY +0.05% |
| 2024Q2ended 2024-06-30 | 2024-08-13 16:30 | -0.260 | -0.300 | -0.260 | 19.26 | 18.30 | EPS -13.3% · sales +5.2% | vs 2023Q2, year-ago quarter · EPS -27.8% · sales +16.6% | 7 EPS · 6 sales | Open +0.27% vs SPY +0.15%. Close -7.01% vs SPY +0.32% |
| 2024Q1ended 2024-03-31 | 2024-05-08 16:30 | -0.320 | -0.321 | -0.316 | 18.12 | 17.33 | EPS -0.4% · sales +4.6% | vs 2023Q1, year-ago quarter · EPS -22.0% · sales +25.2% | 7 EPS · 6 sales | Open -1.43% vs SPY +0.04%. Close -36.75% vs SPY +0.58% |
| 2023Q4ended 2023-12-31 | 2024-03-05 16:30 | -0.230 | -0.315 | -0.231 | 18.01 | 17.41 | EPS -27.0% · sales +3.5% | vs 2022Q4, year-ago quarter · EPS -48.9% · sales +40.8% | 7 EPS · 6 sales | Open +0.70% vs SPY +0.66%. Close -1.55% vs SPY +0.51% |
| 2023Q3ended 2023-09-30 | 2023-11-06 16:30 | -0.280 | -0.404 | -0.279 | 16.43 | 14.23 | EPS -30.7% · sales +15.5% | vs 2022Q3, year-ago quarter · EPS -41.7% · sales +46.7% | 5 EPS · 4 sales | - |
| 2023Q2ended 2023-06-30 | 2023-08-08 16:30 | -0.360 | -0.470 | -0.358 | 16.51 | 12.63 | EPS -23.4% · sales +30.8% | vs 2022Q2, year-ago quarter · EPS -30.8% · sales +61.9% | 5 EPS · 4 sales | - |
| 2023Q1ended 2023-03-31 | 2023-05-04 16:30 | -0.410 | -0.458 | -0.413 | 14.47 | 12.18 | EPS -10.4% · sales +18.9% | vs 2022Q1, year-ago quarter · EPS -12.8% · sales +27.2% | 4 | - |
| 2022Q4ended 2022-12-31 | 2023-03-02 16:30 | -0.450 | -0.500 | -0.449 | 12.79 | 12.40 | EPS -10.0% · sales +3.1% | vs 2021Q4, year-ago quarter · EPS +2.3% · sales +16.3% | 5 EPS · 4 sales | - |
Annual earnings
2025FY EPS -0.660 beat -0.765, from -0.930 a year earlier. Sales 99.99 beat 95.09, from 79.91 a year earlier
Reported years only. The outline behind the bar is the estimate. A later year with no print stays in the table.
earnings feed, not the snapshot. Not the statement ratio.
| Period | EPS adjusted | EPS est | EPS reported | Sales act, USD m | Sales est, USD m | P/E, earnings feed |
|---|---|---|---|---|---|---|
| 2030FYestimate | - | 0.365 | - | - | 224.56 | 21.15 |
| 2029FYestimate | - | 0.120 | - | - | 188.53 | 64.33 |
| 2028FYestimate | - | -0.112 | - | - | 146.23 | - |
| 2027FYestimate | - | -0.275 | - | - | 120 | - |
| 2026FYestimate | - | -0.560 | - | - | 99.28 | - |
| 2025FY | -0.660 | -0.765 | -0.601 | 99.99 | 95.09 | - |
| 2024FY | -0.930 | -0.982 | -0.932 | 79.91 | 79.58 | - |
| 2023FY | -1.270 | -1.362 | -1.275 | 65.42 | 64.48 | - |
| 2022FY | -1.910 | -1.968 | -1.914 | 45.52 | 45.21 | - |
| 2021FY | -2.170 | -1.881 | -1.476 | 45.18 | 44.92 | - |
| 2020FY | -0.900 | - | -1.019 | 41.13 | - | - |
Quarterly results
2026Q3 revenue 23.10, from 27.35 a year earlier. Operating margin -9.0%, from -9.5% a year earlier
From the quarterly statement. Not an estimate.
Estimate revisions
Latest snapshot of each period and type. 2026FY E -0.56 per share.
| Period | Type | Scale | Date | Mean | vs prior date |
|---|---|---|---|---|---|
| 2026FY | E | per share | 2026-11-13 | -0.56 | +1.1% |
| 2026Q4 | E | per share | 2026-11-13 | -0.12 | +8.8% |
| 2026FY | R | per share | 2026-11-13 | -0.56 | +1.1% |
| 2026Q4 | R | per share | 2026-11-13 | -0.12 | +8.8% |
| 2026FY | S | per share | 2026-11-13 | 99.28 | -1.0% |
| 2026Q4 | S | per share | 2026-11-13 | 27.81 | -1.8% |
| 2026Q3 | E | per share | 2026-11-05 | -0.11 | -3.0% |
| 2026Q3 | R | per share | 2026-11-05 | -0.11 | -3.0% |
| 2026Q3 | S | per share | 2026-10-26 | 27.13 | 0.0% |
| 2026Q2 | E | per share | 2026-07-28 | -0.22 | 0.0% |
| 2026Q2 | S | per share | 2026-07-28 | 22.61 | 0.0% |
| 2026Q2 | R | per share | 2026-07-27 | -0.22 | 0.0% |
| 2026Q1 | E | per share | 2026-04-15 | -0.23 | +2.8% |
| 2026Q1 | S | per share | 2026-04-15 | 21.65 | 0.0% |
| 2026Q1 | R | per share | 2026-03-04 | -0.20 | +18.6% |
| 2025Q4 | E | per share | 2026-02-22 | -0.16 | 0.0% |
| 2025Q4 | R | per share | 2026-02-22 | -0.17 | 0.0% |
| 2025Q4 | S | per share | 2026-02-22 | 24.75 | 0.0% |
| 2025FY | S | per share | 2026-02-12 | 95.09 | +0.0% |
| 2025FY | E | per share | 2026-02-06 | -0.77 | +3.0% |
| 2025FY | R | per share | 2026-01-19 | -0.79 | 0.0% |
| 2025Q3 | E | per share | 2025-10-27 | -0.20 | 0.0% |
| 2025Q3 | R | per share | 2025-10-27 | -0.18 | 0.0% |
| 2025Q3 | S | per share | 2025-10-27 | 24.64 | 0.0% |
| 2025Q2 | S | per share | 2025-08-07 | 23.09 | 0.0% |
| 2025Q2 | E | per share | 2025-07-28 | -0.22 | 0.0% |
| 2025Q2 | R | per share | 2025-07-28 | -0.21 | 0.0% |
| 2025Q1 | S | per share | 2025-05-08 | 21.88 | +0.1% |
| 2025Q1 | E | per share | 2025-03-05 | -0.24 | -0.4% |
| 2025Q1 | R | per share | 2025-03-05 | -0.26 | +37.2% |
| 2024FY | E | per share | 2025-02-13 | -0.98 | 0.0% |
| 2024FY | S | per share | 2025-02-13 | 79.58 | +0.0% |
| 2024Q4 | S | per share | 2025-02-13 | 21.14 | 0.0% |
| 2024Q4 | E | per share | 2025-01-30 | -0.22 | -1.2% |
| 2024FY | R | per share | 2025-01-27 | -0.99 | 0.0% |
| 2024Q4 | R | per share | 2025-01-27 | -0.23 | 0.0% |
| 2024Q3 | E | per share | 2024-10-28 | -0.27 | 0.0% |
| 2024Q3 | R | per share | 2024-10-28 | -0.27 | 0.0% |
| 2024Q3 | S | per share | 2024-10-28 | 19.07 | 0.0% |
| 2024Q2 | E | per share | 2024-07-27 | -0.30 | 0.0% |
| 2024Q2 | R | per share | 2024-07-23 | -0.32 | 0.0% |
| 2024Q2 | S | per share | 2024-07-23 | 18.30 | 0.0% |
| 2024Q1 | R | per share | 2024-04-17 | -0.38 | +2.7% |
| 2024Q1 | S | per share | 2024-04-02 | 17.33 | 0.0% |
| 2024Q1 | E | per share | 2024-03-11 | -0.32 | 0.0% |
| 2023FY | E | per share | 2024-01-29 | -1.36 | -0.3% |
| 2023FY | S | per share | 2024-01-29 | 64.48 | +0.2% |
| 2023FY | R | per share | 2024-01-21 | -1.37 | 0.0% |
Estimate history
| Metric | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 | TTM | MRQ |
|---|---|---|---|---|---|---|---|---|---|
| EPS per share | -1.258 | -1.019 | -1.476 | -1.914 | -1.275 | -0.932 | -0.656 | -0.5579 | - |
| Sales USD millions | 37 | 41 | 45 | 46 | 65 | 80 | 100 | 95 | - |
| Shares million shares | 24 | 24 | 24 | 25 | 28 | 30 | 34 | - | 34 |
| Metric | Q3 '24 | Q4 '24 | Q1 '25 | Q2 '25 | Q3 '25 | Q4 '25 | Q1 '26 | Q2 '26 | Q3 '26 |
|---|---|---|---|---|---|---|---|---|---|
| EPS per share | -0.185 | -0.176 | -0.209 | -0.263 | -0.106 | -0.082 | -0.198 | -0.182 | -0.096 |
| Sales USD millions | 21 | 21 | 23 | 24 | 27 | 27 | 22 | 23 | 23 |
| Shares million shares | 30 | 30 | 33 | 33 | 33 | 34 | 34 | 34 | - |
Income statement, annual
| Metric | TTM | 2025FY12/31/2025 | 2024FY12/31/2024 | 2023FY12/31/2023 | 2022FY12/31/2022 | 2021FY12/31/2021 | 2020FY12/31/2020 | 2019FY12/31/2019 |
|---|---|---|---|---|---|---|---|---|
| Total Revenue | 94.59 | 99.99+25.1% | 79.91+22.1% | 65.42+43.7% | 45.52+0.8% | 45.18+9.8% | 41.14+11.3% | 36.97 |
| Cost of Goods Sold Incl. D&A | 16.02 | 22.77+9.4% | 20.82+20.3% | 17.30+32.8% | 13.03+10.9% | 11.75+8.1% | 10.87+3.4% | 10.51 |
| Gross Profit | 78.57 | 77.22+30.7% | 59.09+22.8% | 48.12+48.1% | 32.49-2.8% | 33.44+10.5% | 30.27+14.4% | 26.46 |
| Selling, General and Administrative Excl. Other | 91.56 | 93.56+15.8% | 80.76+7.3% | 75.30+2.7% | 73.29+28.2% | 57.17+32.0% | 43.32-10.7% | 48.49 |
| Research and Development | 27.28 | 27.89+17.9% | 23.65+13.8% | 20.78-5.3% | 21.95+20.5% | 18.21+16.0% | 15.70-14.2% | 18.29 |
| Other Operating Expense | - | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Operating Income | -14.56 | -16.34 | -21.67 | -27.17 | -40.79 | -23.74 | -13.05 | -22.03 |
| Interest Expense | 6.22 | 7.46-15.2% | 8.80+3.3% | 8.52+13.1% | 7.53+1.6% | 7.41-35.5% | 11.49+21.2% | 9.48 |
| Unusual Expense | - | 0.49 | -0.30-193.8% | 0.32 | 0.00-100.0% | 5.24 | -0.33 | -1.28 |
| Net Income Before Taxes | -18.92 | -21.46 | -27.14 | -32.96 | -47.08 | -36.08 | -24.28 | -29.97 |
| Income Taxes | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Consolidated Net Income | -18.92 | -21.46 | -27.14 | -32.96 | -47.08 | -36.08 | -24.28 | -29.97 |
| Net Income From Continuing Operations | -18.92 | -21.46 | -27.14 | -32.96 | -47.08 | -36.08 | -24.28 | -29.97 |
| Net Income | -18.92 | -21.46 | -27.14 | -32.96 | -47.08 | -36.08 | -24.28 | -29.97 |
| EPS (Recurring) per share | -0.55 | -0.65 | -0.94 | -1.27 | -1.91 | -1.33 | -1.03 | -1.30 |
| EPS (Basic, Before Extraordinaries) per share | -0.56 | -0.66 | -0.93 | -1.27 | -1.91 | -1.48 | -1.02 | -1.26 |
| EPS (Diluted) per share | -0.56 | -0.66 | -0.93 | -1.27 | -1.91 | -1.48 | -1.02 | -1.26 |
| EBITDA | -12.44 | -14.39 | -19.90 | -25.57 | -37.81 | -23.44 | -12.74 | -21.61 |
| Non-Operating Income (Expense) | 2.07 | 2.82-6.6% | 3.02-1.0% | 3.05+146.0% | 1.24+313.3% | 0.30 | -0.07-125.9% | 0.27 |
| Other After Tax Adjustments | - | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Stock Option Compensation Expense | - | 11.09+7.9% | 10.28+7.5% | 9.56+14.5% | 8.35+94.6% | 4.29+210.9% | 1.38-4.2% | 1.44 |
| Price To Sales Ratio ratio | - | 5.05 | 4.08 | 4.07 | 0.81 | 5.46 | - | - |
| Gross Margin % | 83.07 | 77.23 | 73.94 | 73.56 | 71.38 | 74.00 | 73.59 | 71.58 |
| Operating Margin % | -15.39 | -16.34 | -27.12 | -41.54 | -89.62 | -52.54 | -31.72 | -59.59 |
| Net Margin % | -20.00 | -21.47 | -33.97 | -50.38 | -103.43 | -79.85 | -59.02 | -81.07 |
| Shares Outstanding million shares | - | 33.57+11.3% | 30.15+8.4% | 27.82+11.1% | 25.05+2.5% | 24.45+2.6% | 23.830.0% | 23.83 |
| Market Capitalization | 412.58 | 412.58+23.5% | 334.00+23.3% | 270.98+630.2% | 37.11-84.9% | 245.09+8.9% | 225.15 | - |
Income statement, quarterly
| Metric | 2026Q39/30/2026 | 2026Q26/30/2026 | 2026Q13/31/2026 | 2025Q412/31/2025 | 2025Q39/30/2025 | 2025Q26/30/2025 | 2025Q13/31/2025 | 2024Q412/31/2024 |
|---|---|---|---|---|---|---|---|---|
| Total Revenue | 23.10-15.5% | 22.83-2.9% | 22.07-2.0% | 26.59+23.8% | 27.35+29.9% | 23.52+22.1% | 22.52+24.3% | 21.47+19.2% |
| Cost of Goods Sold Incl. D&A | 3.63-41.4% | 3.92-27.3% | 4.02-22.4% | 6.01+13.8% | 6.19+9.8% | 5.39+5.3% | 5.18+8.4% | 5.28+18.1% |
| Gross Profit | 19.47-8.0% | 18.91+4.3% | 18.05+4.1% | 20.58+27.1% | 21.17+37.3% | 18.13+28.3% | 17.34+30.0% | 16.19+19.6% |
| Selling, General and Administrative Excl. Other | 21.55-9.3% | 24.05-3.6% | 23.62+5.0% | 22.34+12.6% | 23.77+20.9% | 24.96+22.6% | 22.49+7.7% | 19.84+6.7% |
| Research and Development | 6.17-6.2% | 6.90+0.9% | 7.19-3.4% | 7.03+16.2% | 6.58+14.4% | 6.84+12.7% | 7.44+28.7% | 6.05+12.5% |
| Other Operating Expense | - | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Operating Income | -2.08 | -5.14 | -5.57 | -1.77 | -2.60 | -6.82 | -5.15 | -3.65 |
| Interest Expense | 1.56-5.5% | 1.54-25.2% | 1.52-29.3% | 1.60-26.9% | 1.65-24.3% | 2.06-5.1% | 2.15-4.9% | 2.19-2.2% |
| Unusual Expense | - | 0.04-91.8% | 0.17+112.5% | 0.00-100.0% | -0.08 | 0.49 | 0.08 | 0.09 |
| Net Income Before Taxes | -3.30 | -6.20 | -6.69 | -2.73 | -3.50 | -8.65 | -6.59 | -5.25 |
| Income Taxes | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Consolidated Net Income | -3.30 | -6.20 | -6.69 | -2.73 | -3.50 | -8.65 | -6.59 | -5.25 |
| Net Income From Continuing Operations | -3.30 | -6.20 | -6.69 | -2.73 | -3.50 | -8.65 | -6.59 | -5.25 |
| Net Income | -3.30 | -6.20 | -6.69 | -2.73 | -3.50 | -8.65 | -6.59 | -5.25 |
| EPS (Recurring) per share | -0.10 | -0.18 | -0.19 | -0.08 | -0.11 | -0.25 | -0.21 | -0.17 |
| EPS (Basic, Before Extraordinaries) per share | -0.10 | -0.18 | -0.20 | -0.08 | -0.11 | -0.26 | -0.21 | -0.18 |
| EPS (Diluted) per share | -0.10 | -0.18 | -0.20 | -0.08 | -0.11 | -0.26 | -0.21 | -0.18 |
| EBITDA | -1.52 | -4.61 | -5.05 | -1.25 | -2.11 | -6.35 | -4.68 | -0.57 |
| Non-Operating Income (Expense) | 0.35-47.8% | 0.52-27.8% | 0.56-29.1% | 0.64-5.9% | 0.67-10.7% | 0.72-5.3% | 0.79-4.8% | 0.68-17.1% |
| Other After Tax Adjustments | - | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Stock Option Compensation Expense | - | 2.30-28.8% | 2.28-13.3% | 2.63+1.2% | 2.63+1.5% | 3.23+26.7% | 2.63+3.5% | 2.60+10.2% |
| Price To Sales Ratio ratio | - | 5.48 | 4.45 | 5.16 | 3.60 | 4.13 | 4.59 | 4.19 |
| Gross Margin % | 84.28 | 82.83 | 81.78 | 77.40 | 77.39 | 77.09 | 76.99 | 75.41 |
| Operating Margin % | -9.00 | -22.53 | -25.23 | -6.65 | -9.51 | -29.01 | -22.85 | -17.02 |
| Net Margin % | -14.27 | -27.16 | -30.31 | -10.26 | -12.78 | -36.78 | -29.25 | -24.46 |
| Shares Outstanding million shares | - | 34.28+3.8% | 33.91+3.5% | 33.57+11.3% | 33.28+11.8% | 33.04+13.4% | 32.75+14.0% | 30.15+8.4% |
| Market Capitalization | 412.58+21.0% | 541.75+48.3% | 442.72+10.6% | 514.27+54.0% | 341.07+67.6% | 365.38+68.0% | 400.16+7.0% | 334.00+23.3% |
Balance sheet, annual
| Metric | 2025FY12/31/2025 | 2024FY12/31/2024 | 2023FY12/31/2023 | 2022FY12/31/2022 | 2021FY12/31/2021 | 2020FY12/31/2020 | 2019FY12/31/2019 |
|---|---|---|---|---|---|---|---|
| Cash & Short Term Investments | 61.06+15.7% | 52.76-20.6% | 66.45-14.2% | 77.41-33.0% | 115.58+203.5% | 38.08+648.1% | 5.09 |
| Short Term Receivables | 14.68+14.2% | 12.85+4.4% | 12.31+64.6% | 7.48+5.5% | 7.09-15.5% | 8.39+39.4% | 6.02 |
| Inventories | 16.90+26.3% | 13.38+19.4% | 11.21+15.4% | 9.71+24.2% | 7.82+13.2% | 6.91-12.5% | 7.90 |
| Other Current Assets | 1.44-38.7% | 2.35-14.2% | 2.74-11.9% | 3.11+34.1% | 2.32+96.6% | 1.18-5.6% | 1.25 |
| Total Current Assets | 94.07+15.7% | 81.34-12.3% | 92.72-5.1% | 97.71-26.4% | 132.82+143.4% | 54.56+169.3% | 20.26 |
| Net Property, Plant & Equipment | 11.26-12.6% | 12.89-10.5% | 14.41-9.4% | 15.90+2550.0% | 0.60+15.4% | 0.52-35.8% | 0.81 |
| Total Investments and Advances | 0.120.0% | 0.120.0% | 0.120.0% | 0.120.0% | 0.12-67.6% | 0.37 | 0.00 |
| Deferred Tax Assets | 88.37 | - | - | - | - | - | - |
| Other Assets | 0.11-62.1% | 0.29-27.5% | 0.40+8.1% | 0.37+1750.0% | 0.02-96.1% | 0.51+1600.0% | 0.03 |
| Total Assets | 193.94+104.9% | 94.65-12.1% | 107.65-5.7% | 114.11-14.6% | 133.56+138.7% | 55.95+165.3% | 21.09 |
| Short Term Debt Incl. Current Port. of LT Debt | 2.12+14.0% | 1.86+14.1% | 1.63+14.8% | 1.42 | 0.00-100.0% | 2.04-96.8% | 62.80 |
| Accounts Payable | 2.22-24.7% | 2.95+26.6% | 2.33+8.4% | 2.15+55.8% | 1.38+45.3% | 0.95+5.6% | 0.90 |
| Other Current Liabilities | 13.48+30.4% | 10.34-15.7% | 12.27+65.6% | 7.41-6.4% | 7.92+20.0% | 6.60-42.4% | 11.45 |
| Total Current Liabilities | 17.81+17.5% | 15.16-6.6% | 16.23+47.8% | 10.98+18.1% | 9.30-3.1% | 9.60-87.2% | 75.15 |
| Long Term Debt | 68.72-3.9% | 71.48+1.0% | 70.77+3.5% | 68.35+37.1% | 49.85-2.6% | 51.19 | 0.00 |
| Provision for Risks Charges | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Deferred Tax Liabilities | 88.37 | - | - | - | - | - | - |
| Other Liabilities | 0.00 | 0.00 | 0.00 | 0.00-100.0% | 0.91-42.0% | 1.57-9.2% | 1.73 |
| Total Liabilities | 174.90+101.9% | 86.63-0.4% | 87.00+9.7% | 79.33+32.1% | 60.06-3.7% | 62.36-18.9% | 76.88 |
| Non-Equity Reserves | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Preferred Stock - Carrying Value | 0.00 | 0.00 | 0.00 | 0.00 | 0.00-100.0% | 141.42+92.2% | 73.57 |
| Common Equity | 19.03+137.6% | 8.01-61.2% | 20.65-40.6% | 34.78-52.7% | 73.50 | -147.83 | -129.35 |
| Total Shareholders Equity | 19.03+137.6% | 8.01-61.2% | 20.65-40.6% | 34.78-52.7% | 73.50 | -6.41 | -55.78 |
| Accumulated Minority Interest | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Total Equity | 19.03+137.6% | 8.01-61.2% | 20.65-40.6% | 34.78-52.7% | 73.50 | -6.41 | -55.78 |
| Total Liabilities & Stockholders Equity | 193.94+104.9% | 94.65-12.1% | 107.65-5.7% | 114.11-14.6% | 133.56+138.7% | 55.95+165.3% | 21.09 |
| Book Value Per Share per share | 0.57+111.1% | 0.27-63.5% | 0.74-46.8% | 1.39-53.8% | 3.01 | -6.20 | -5.43 |
| Tangible Book Value Per Share per share | 0.57+111.1% | 0.27-63.5% | 0.74-46.8% | 1.39-53.8% | 3.01 | -6.20 | -5.43 |
| Full-Time Employees people | 209+13.6% | 184+7.6% | 171+2.4% | 167+0.6% | 166+9.2% | 1520.0% | 152 |
| Price to Book Ratio ratio | 34.68 | 33.92 | 16.54 | 0.85 | 3.35 | 2.75 | - |
| Return on Assets % | -14.88 | -26.83 | -29.72 | -38.02 | -38.08 | -63.02 | - |
| Return on Equity % | -158.74 | -189.35 | -118.91 | -86.96 | -107.55 | - | - |
| Return on Invested Capital % | -24.46 | -34.14 | -36.05 | -45.65 | -29.25 | -54.22 | - |
| Quick Ratio ratio | 4.33 | 4.48 | 5.02 | 8.02 | 13.44 | 4.97 | 0.16 |
| Current Ratio ratio | 5.28 | 5.37 | 5.71 | 8.90 | 14.28 | 5.69 | 0.27 |
Cash flow, annual
| Metric | TTM | 2025FY12/31/2025 | 2024FY12/31/2024 | 2023FY12/31/2023 | 2022FY12/31/2022 | 2021FY12/31/2021 | 2020FY12/31/2020 | 2019FY12/31/2019 |
|---|---|---|---|---|---|---|---|---|
| Net Income | -18.92 | -21.46 | -27.14 | -32.96 | -47.08 | -36.08 | -24.28 | -29.97 |
| Depreciation | 2.12 | 1.95+10.2% | 1.77+10.6% | 1.60-46.5% | 2.99+896.7% | 0.30-3.2% | 0.31-26.2% | 0.42 |
| Other Funds (Non Cash) | 10.92 | 12.52-2.8% | 12.88-8.8% | 14.13+17.7% | 12.01+10.8% | 10.84+145.2% | 4.42-2.2% | 4.52 |
| Funds from Operations | -5.88 | -6.99 | -12.50 | -17.22 | -32.08 | -24.95 | -19.54 | -25.04 |
| Extraordinary Item | - | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Changes in Working Capital | -6.18 | -4.01 | -5.45 | -2.48 | -4.79-1394.6% | 0.37 | -2.07-20800.0% | 0.01 |
| Cash from Operating Activities | -12.06 | -11.01 | -17.95 | -19.70 | -36.87 | -24.58 | -21.61 | -25.03 |
| Capital Expenditures | -0.35 | -0.33 | -0.31 | -0.17 | -0.60 | -0.38 | -0.06 | -0.47 |
| Net Assets From Acquisitions | - | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Sale of Fixed Assets and Businesses | - | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Purchase or Sale of Investments | - | 0.00-100.0% | 9.30-59.9% | 23.20-4.9% | 24.40 | -85.01 | -10.71-362.5% | 4.08 |
| Purchase of Investments | - | 0.00 | 0.00 | 0.00 | 0.00 | -85.01 | -17.00 | -18.02 |
| Sale Or Maturity of Investments | - | 0.00-100.0% | 9.30-59.9% | 23.20-4.9% | 24.40 | 0.00-100.0% | 6.30-71.5% | 22.10 |
| Other Uses | - | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Other Sources | - | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Cash from Investing Activities | -0.35 | -0.33-103.7% | 8.99-61.0% | 23.03-3.2% | 23.80 | -85.40 | -10.77-397.5% | 3.62 |
| Cash Dividends Paid | - | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Change in Capital Stock | 2.65 | 22.21+326.3% | 5.21-37.9% | 8.39+1425.5% | 0.55-99.5% | 106.62+238.5% | 31.50+78650.0% | 0.04 |
| Repurchase of Common Pref Stock | - | -49.55 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Sale of Common Pref Stock | 2.65 | 71.76+1277.4% | 5.21-37.9% | 8.39+1425.5% | 0.55-99.5% | 106.62+238.5% | 31.50+78650.0% | 0.04 |
| Proceedsfrom Stock Options | 1.93 | 69.65 | 0.00 | -0.30 | -0.35-100.3% | 105.70+235.7% | 31.49 | 0.00 |
| Issuance or Reduction of Debt, Net | -0.15 | -2.07 | 0.00 | 0.00 | 0.00 | -4.09-117.4% | 23.51+10.2% | 21.33 |
| Change in Long Term Debt | -0.15 | -2.07 | 0.00 | 0.00 | 0.00 | -4.09-137.2% | 10.98 | 0.00 |
| Issuance of Long Term Debt | - | 58.44 | 0.00 | 0.00 | 0.00 | 0.00-100.0% | 53.10 | 0.00 |
| Reduction of Long Term Debt | -0.15 | -60.51 | 0.00 | 0.00 | 0.00 | -4.09 | -42.12 | 0.00 |
| Net Financing Active Other Cash Flow | -0.38 | -0.54 | -0.88 | -0.26 | -0.06 | 0.00 | 0.00 | 0.00 |
| Other Financing Activities Uses | -0.38 | -0.54 | -0.88 | -0.26 | -0.06 | 0.00 | 0.00 | 0.00 |
| Cash from Financing Activities | 2.12 | 19.60+352.7% | 4.33-46.7% | 8.13+1559.2% | 0.49-99.5% | 102.53+86.4% | 55.01+157.4% | 21.37 |
| Net Change in Cash | -10.29 | 8.26 | -4.63-140.4% | 11.45 | -12.58 | -7.45-132.9% | 22.63 | -0.04 |
| Free Cash Flow | -12.41 | -11.34 | -18.25 | -19.87 | -37.47 | -24.96 | -21.67 | -25.49 |
| Preferred Dividends (Cash Flow) | - | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Deferred Taxes & Investment Tax Credit | - | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
Balance sheet, quarterly
| Metric | 2026Q39/30/2026 | 2026Q26/30/2026 | 2026Q13/31/2026 | 2025Q412/31/2025 | 2025Q39/30/2025 | 2025Q26/30/2025 | 2025Q13/31/2025 | 2024Q412/31/2024 |
|---|---|---|---|---|---|---|---|---|
| Cash & Short Term Investments | 49.23-18.0% | 51.70-16.8% | 53.98-18.5% | 61.06+15.7% | 60.01+5.6% | 62.14+11.9% | 66.26+12.4% | 52.76-20.6% |
| Short Term Receivables | 14.28-4.4% | 14.93+10.2% | 14.79-4.2% | 14.68+14.2% | 14.94+29.2% | 13.55+20.6% | 15.44+32.8% | 12.85+4.4% |
| Inventories | 18.80+3.6% | 18.11+10.8% | 16.69+22.9% | 16.90+26.3% | 18.14+50.2% | 16.35+43.9% | 13.58+18.9% | 13.38+19.4% |
| Other Current Assets | 2.23-0.4% | 1.45-14.7% | 1.51-31.4% | 1.44-38.7% | 2.24+5.7% | 1.70-18.3% | 2.20-2.7% | 2.35-14.2% |
| Total Current Assets | 84.54-11.3% | 86.19-8.1% | 86.98-10.8% | 94.07+15.7% | 95.33+15.4% | 93.74+16.8% | 97.48+15.7% | 81.34-12.3% |
| Net Property, Plant & Equipment | 9.90-15.2% | 10.46-14.0% | 10.96-12.9% | 11.26-12.6% | 11.68-12.1% | 12.16-10.9% | 12.59-10.5% | 12.89-10.5% |
| Total Investments and Advances | 0.24+100.0% | 0.24+100.0% | 0.85+608.3% | 0.120.0% | 0.120.0% | 0.120.0% | 0.120.0% | 0.120.0% |
| Deferred Tax Assets | - | - | - | 88.37 | - | - | - | - |
| Other Assets | 0.09-25.0% | 0.10+11.1% | 0.11+1000.0% | 0.11-62.1% | 0.12-60.0% | 0.09-77.5% | 0.01-97.5% | 0.29-27.5% |
| Total Assets | 94.78-11.6% | 96.99-8.6% | 98.90-10.3% | 193.94+104.9% | 107.25+11.4% | 106.11+12.4% | 110.20+11.5% | 94.65-12.1% |
| Short Term Debt Incl. Current Port. of LT Debt | 2.33+13.7% | 2.26+13.6% | 2.19+14.1% | 2.12+14.0% | 2.05+13.9% | 1.99+14.4% | 1.92+14.3% | 1.86+14.1% |
| Accounts Payable | 3.24-29.4% | 4.20-11.0% | 4.51+11.4% | 2.22-24.7% | 4.59+112.5% | 4.72+106.1% | 4.05+23.9% | 2.95+26.6% |
| Other Current Liabilities | 10.50-19.0% | 10.97+5.1% | 9.47+8.4% | 13.48+30.4% | 12.97+19.9% | 10.44+22.1% | 8.74+7.1% | 10.34-15.7% |
| Total Current Liabilities | 16.07-18.1% | 17.43+1.7% | 16.17+9.9% | 17.81+17.5% | 19.61+32.7% | 17.14+36.1% | 14.71+12.2% | 15.16-6.6% |
| Long Term Debt | 67.21-2.8% | 67.67-2.7% | 68.28-4.1% | 68.72-3.9% | 69.13-3.6% | 69.53-3.3% | 71.23-0.2% | 71.48+1.0% |
| Provision for Risks Charges | - | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Deferred Tax Liabilities | - | - | - | 88.37 | - | - | - | - |
| Other Liabilities | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Total Liabilities | 83.28-6.2% | 85.11-1.8% | 84.44-1.7% | 174.90+101.9% | 88.74+2.6% | 86.68+2.6% | 85.94+1.7% | 86.63-0.4% |
| Non-Equity Reserves | - | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Preferred Stock - Carrying Value | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Common Equity | 11.49-38.0% | 11.88-38.9% | 14.45-40.5% | 19.03+137.6% | 18.52+88.6% | 19.44+96.8% | 24.27+69.2% | 8.01-61.2% |
| Total Shareholders Equity | 11.49-38.0% | 11.88-38.9% | 14.45-40.5% | 19.03+137.6% | 18.52+88.6% | 19.44+96.8% | 24.27+69.2% | 8.01-61.2% |
| Accumulated Minority Interest | - | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Total Equity | 11.49-38.0% | 11.88-38.9% | 14.45-40.5% | 19.03+137.6% | 18.52+88.6% | 19.44+96.8% | 24.27+69.2% | 8.01-61.2% |
| Total Liabilities & Stockholders Equity | 94.78-11.6% | 96.99-8.6% | 98.90-10.3% | 193.94+104.9% | 107.25+11.4% | 106.11+12.4% | 110.20+11.5% | 94.65-12.1% |
| Book Value Per Share per share | - | 0.35-40.7% | 0.43-41.9% | 0.57+111.1% | 0.56+69.7% | 0.59+73.5% | 0.74+48.0% | 0.27-63.5% |
| Tangible Book Value Per Share per share | - | 0.35-40.7% | 0.43-41.9% | 0.57+111.1% | 0.56+69.7% | 0.59+73.5% | 0.74+48.0% | 0.27-63.5% |
| Full-Time Employees people | - | - | - | 209+13.6% | - | - | - | 184+7.6% |
| Price to Book Ratio ratio | 34.68 | 37.28 | 23.20 | 27.75 | 17.53 | 15.03 | 46.24 | 33.92 |
| Return on Assets % | -18.73 | -18.82 | -20.63 | -14.88 | -23.57 | -25.88 | -23.73 | -26.83 |
| Return on Equity % | -126.06 | -122.05 | -111.38 | -158.74 | -169.27 | -176.94 | -128.49 | -189.35 |
| Return on Invested Capital % | -4.19 | -7.79 | -8.09 | -3.11 | -3.99 | -9.72 | -6.90 | -6.60 |
| Quick Ratio ratio | 4.09 | 3.91 | 4.35 | 4.33 | 3.94 | 4.51 | 5.70 | 4.48 |
| Current Ratio ratio | 5.26 | 4.94 | 5.38 | 5.28 | 4.86 | 5.47 | 6.63 | 5.37 |
Cash flow, quarterly
| Metric | 2026Q39/30/2026 | 2026Q26/30/2026 | 2026Q13/31/2026 | 2025Q412/31/2025 | 2025Q39/30/2025 | 2025Q26/30/2025 | 2025Q13/31/2025 | 2024Q412/31/2024 |
|---|---|---|---|---|---|---|---|---|
| Net Income | -3.30 | -6.20 | -6.69 | -2.73 | -3.50 | -8.65 | -6.59 | -5.25 |
| Depreciation | 0.56+14.3% | 0.53+10.4% | 0.51+10.9% | 0.52+15.6% | 0.49+8.9% | 0.48+9.1% | 0.46+9.5% | 0.45+9.8% |
| Other Funds (Non Cash) | 2.91+6.2% | 2.56-36.0% | 2.66-11.9% | 2.78-7.3% | 2.74+0.4% | 4.00+13.6% | 3.02-16.6% | 3.00-7.7% |
| Funds from Operations | 0.17 | -3.11 | -3.51 | 0.57 | -0.27 | -4.18 | -3.11 | -1.79 |
| Extraordinary Item | - | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Changes in Working Capital | -2.93 | -0.80-138.3% | -2.39 | -0.06 | -1.67-403.6% | 2.09 | -4.37 | -3.00 |
| Cash from Operating Activities | -2.76 | -3.90 | -5.90 | 0.51 | -1.94 | -2.09 | -7.48 | -4.80 |
| Capital Expenditures | -0.02 | -0.12 | -0.12 | -0.10 | -0.03 | -0.17 | -0.04 | -0.04 |
| Net Assets From Acquisitions | - | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Sale of Fixed Assets and Businesses | - | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Purchase or Sale of Investments | - | 0.00 | 0.00 | 0.00-100.0% | 0.00-100.0% | 0.00-100.0% | 0.00-100.0% | 2.00-42.9% |
| Purchase of Investments | - | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Sale Or Maturity of Investments | - | 0.00 | 0.00 | 0.00-100.0% | 0.00-100.0% | 0.00-100.0% | 0.00-100.0% | 2.00-42.9% |
| Other Uses | - | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Other Sources | - | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Cash from Investing Activities | -0.02 | -0.12 | -0.12 | -0.10-105.1% | -0.03-102.1% | -0.17-105.2% | -0.04-101.7% | 1.96-43.5% |
| Cash Dividends Paid | - | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Preferred Dividends (Cash Flow) | - | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Change in Capital Stock | 0.54 | 1.38+590.0% | 0.01-100.0% | 0.72-23.4% | -0.05-101.7% | 0.20-65.5% | 21.34+2863.9% | 0.94-88.6% |
| Repurchase of Common Pref Stock | - | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | -49.55 | 0.00 |
| Sale of Common Pref Stock | 0.54 | 1.38+590.0% | 0.01-100.0% | 0.72-23.4% | -0.05-101.7% | 0.20-65.5% | 70.88+9744.4% | 0.94-88.6% |
| Proceedsfrom Stock Options | 1.93 | 0.00 | 0.00-100.0% | 0.00 | -0.05 | -0.56 | 70.27 | 0.00 |
| Issuance or Reduction of Debt, Net | -0.15 | 0.00 | 0.00 | 0.00 | -0.13 | -1.94 | 0.00 | 0.00 |
| Change in Long Term Debt | -0.15 | 0.00 | 0.00 | 0.00 | -0.13 | -1.94 | 0.00 | 0.00 |
| Issuance of Long Term Debt | - | 0.00-100.0% | 0.00 | 0.00 | -0.13 | 58.57 | 0.00 | 0.00 |
| Reduction of Long Term Debt | -0.15 | 0.00 | 0.00 | 0.00 | 0.00 | -60.51 | 0.00 | 0.00 |
| Net Financing Active Other Cash Flow | 0.09 | -0.20 | -0.18 | -0.09 | -0.05 | -0.17 | -0.23 | -0.09 |
| Other Financing Activities Uses | 0.09 | -0.20 | -0.18 | -0.09 | -0.05 | -0.17 | -0.23 | -0.09 |
| Cash from Financing Activities | 0.48 | 1.18 | -0.17-100.8% | 0.64-24.7% | -0.23-107.9% | -1.91-474.5% | 21.11+30057.1% | 0.85-89.6% |
| Net Change in Cash | -2.30 | -2.85 | -6.18-145.5% | 1.04 | -2.21-186.0% | -4.16 | 13.59 | -1.99-123.9% |
| Free Cash Flow | -2.78 | -4.03 | -6.02 | 0.41 | -1.97 | -2.25 | -7.52 | -4.84 |
Revenue breakdown
USD millions, so a column adds up to the income statement. Share is of the latest year in that split. The change is versus the older year shown, not TTM.
| Name | 2024 | 2025 | vs 2024 | 2025 share |
|---|---|---|---|---|
| Surgical & Medical Instruments & Apparatus | 79.91 | 99.99 | +25.1% | 100.0% |
| Total | 79.91 | 99.99 | +25.1% | 100.0% |
| Name | 2024 | 2025 | vs 2024 | 2025 share |
|---|---|---|---|---|
| United States | 79.91 | 99.99 | +25.1% | 100.0% |
| Total | 79.91 | 99.99 | +25.1% | 100.0% |
Short interest
shares short against float, oldest to newest| Settlement | Of float | Shares short | Float | Avg volume |
|---|---|---|---|---|
| 2026-10-30 | 3.20% | 0.9M | 26.8M | 147.70K |
| 2026-10-15 | 3.31% | 0.9M | 26.8M | 164.31K |
| 2026-09-30 | 3.37% | 0.9M | 26.8M | 172.26K |
| 2026-09-15 | 3.57% | 1.0M | 26.8M | 185.56K |
| 2026-08-31 | 3.39% | 0.9M | 26.9M | 189.10K |
| 2026-08-14 | 3.14% | 0.8M | 26.9M | 189.84K |
| 2026-07-31 | 3.15% | 0.8M | 26.1M | 193.99K |
| 2026-07-15 | 3.35% | 0.9M | 26.1M | 185.58K |
| 2026-06-30 | 3.44% | 0.9M | 26.1M | 184.95K |
| 2026-06-15 | 2.35% | 0.6M | 26.1M | 184.29K |
| 2026-05-29 | 2.23% | 0.6M | 26.1M | 210.53K |
| 2026-05-15 | 2.35% | 0.6M | 26.1M | 211.43K |
| 2026-04-30 | 3.01% | 0.8M | 25.7M | 193.58K |
| 2026-04-15 | 3.60% | 0.9M | 25.5M | 189.80K |
| 2026-03-31 | 3.74% | 0.9M | 25.3M | 225.30K |
| 2026-03-13 | 3.71% | 0.9M | 25.3M | 216.80K |
| 2026-02-27 | 3.18% | 0.8M | 25.3M | 205.63K |
| 2026-02-13 | 3.47% | 0.9M | 25.1M | 222.91K |
| 2026-01-30 | 3.19% | 0.8M | 24.9M | 250.36K |
| 2026-01-15 | 3.60% | 0.9M | 24.9M | 245.14K |
Option chain
expiry 2026-11-20| Type | Strike | Bid | Ask | Last | IV | Open int | Volume | Delta | Theta | Vega |
|---|---|---|---|---|---|---|---|---|---|---|
| call | 2.50 | 8.00 | 11.10 | 0.00 | 18.004 | 0.00 | 0.00 | 0.989 | -0.019 | 0.001 |
| call | 5.00 | 5.80 | 8.80 | 0.00 | 10.386 | 0.00 | 0.00 | 0.980 | -0.018 | 0.001 |
| call | 7.50 | 2.95 | 6.30 | 0.00 | 6.669 | 0.00 | 0.00 | 0.848 | -0.127 | 0.004 |
| call | 10.00 | 1.00 | 3.80 | 0.00 | 4.218 | 0.00 | 0.00 | 0.744 | -0.102 | 0.006 |
| call | 12.50 | 0.10 | 1.25 | 0.35 | 2.064 | 3.00 | 10.00 | 0.513 | -0.096 | 0.007 |
| call | 15.00 | 0.00 | 2.00 | 0.25 | 3.149 | 112 | 0.00 | 0.402 | -0.137 | 0.007 |
| call | 17.50 | 0.00 | 4.90 | 2.50 | 3.905 | 3.00 | 0.00 | 0.356 | -0.164 | 0.007 |
| call | 20.00 | 0.00 | 1.20 | 0.05 | 3.531 | 130 | 0.00 | 0.249 | -0.126 | 0.006 |
| call | 22.50 | 0.00 | 4.90 | 1.50 | 4.899 | 2.00 | 0.00 | 0.304 | -0.193 | 0.006 |
| call | 25.00 | 0.00 | 4.90 | 2.26 | 5.309 | 4.00 | 0.00 | 0.291 | -0.205 | 0.006 |
| call | 30.00 | 0.00 | 4.90 | 0.00 | 5.978 | 0.00 | 0.00 | 0.273 | -0.223 | 0.006 |
| call | 35.00 | 0.00 | 4.90 | 0.00 | 6.512 | 0.00 | 0.00 | 0.261 | -0.238 | 0.006 |
| put | 2.50 | 0.00 | 2.65 | 0.00 | 5.708 | 0.00 | 0.00 | -0.011 | -0.018 | 0.001 |
| put | 5.00 | 0.00 | 2.65 | 0.00 | 3.298 | 0.00 | 0.00 | -0.020 | -0.018 | 0.001 |
| put | 7.50 | 0.00 | 4.90 | 0.00 | 4.760 | 0.00 | 0.00 | -0.152 | -0.126 | 0.004 |
| put | 10.00 | 0.00 | 0.95 | 0.10 | 2.794 | 6.00 | 0.00 | -0.257 | -0.101 | 0.006 |
| put | 12.50 | 0.65 | 1.85 | 1.45 | 2.251 | 6.00 | 10.00 | -0.487 | -0.094 | 0.007 |
| put | 15.00 | 2.00 | 4.90 | 3.02 | 4.133 | 4.00 | 0.00 | -0.598 | -0.136 | 0.007 |
| put | 17.50 | 3.90 | 7.10 | 0.00 | 4.479 | 0.00 | 0.00 | -0.644 | -0.162 | 0.007 |
| put | 20.00 | 6.50 | 10.00 | 0.00 | 5.674 | 0.00 | 0.00 | -0.678 | -0.176 | 0.006 |
| put | 22.50 | 9.10 | 12.00 | 0.00 | 5.435 | 0.00 | 0.00 | -0.696 | -0.190 | 0.006 |
| put | 25.00 | 10.90 | 15.00 | 0.00 | 6.612 | 0.00 | 0.00 | -0.709 | -0.202 | 0.006 |
| put | 30.00 | 15.90 | 19.90 | 0.00 | 7.166 | 0.00 | 0.00 | -0.727 | -0.220 | 0.006 |
| put | 35.00 | 20.60 | 24.80 | 0.00 | 7.573 | 0.00 | 0.00 | -0.739 | -0.234 | 0.006 |
Latest SEC filings
30| Filed | Form | Description | Period | Link |
|---|---|---|---|---|
| 2026-11-12 | 10-Q | Quarterly report pursuant to Section 13 or 15(d) | 2026-09-30 | SEC |
| 2026-11-12 | 8-K | Current report | 2026-11-12 | SEC |
| 2026-09-25 | 4 | Statement of changes in beneficial ownership of securities | 2026-09-24 | SEC |
| 2026-09-21 | 4 | Statement of changes in beneficial ownership of securities | 2026-09-20 | SEC |
| 2026-09-04 | SCHEDULE 13G/A | SEC | ||
| 2026-09-04 | 4 | Statement of changes in beneficial ownership of securities | 2026-09-03 | SEC |
| 2026-08-28 | 4 | Statement of changes in beneficial ownership of securities | 2026-08-27 | SEC |
| 2026-08-28 | 4 | Statement of changes in beneficial ownership of securities | 2026-08-27 | SEC |
| 2026-08-14 | SCHEDULE 13G/A | SEC | ||
| 2026-08-11 | 10-Q | Quarterly report pursuant to Section 13 or 15(d) | 2026-06-30 | SEC |
| 2026-08-11 | 8-K | Current report | 2026-08-11 | SEC |
| 2026-07-28 | 8-K | Current report | 2026-07-28 | SEC |
| 2026-06-25 | 4 | Statement of changes in beneficial ownership of securities | 2026-06-24 | SEC |
| 2026-06-22 | 4 | Statement of changes in beneficial ownership of securities | 2026-06-19 | SEC |
| 2026-06-22 | 4 | Statement of changes in beneficial ownership of securities | 2026-06-19 | SEC |
| 2026-06-22 | 4 | Statement of changes in beneficial ownership of securities | 2026-06-19 | SEC |
| 2026-06-08 | 8-K | Current report | 2026-06-05 | SEC |
| 2026-06-05 | 4 | Statement of changes in beneficial ownership of securities | 2026-06-05 | SEC |
| 2026-06-05 | 4 | Statement of changes in beneficial ownership of securities | 2026-06-05 | SEC |
| 2026-06-05 | 4 | Statement of changes in beneficial ownership of securities | 2026-06-05 | SEC |
| 2026-06-05 | 4 | Statement of changes in beneficial ownership of securities | 2026-06-05 | SEC |
| 2026-06-05 | 4 | Statement of changes in beneficial ownership of securities | 2026-06-05 | SEC |
| 2026-06-05 | 4 | Statement of changes in beneficial ownership of securities | 2026-06-05 | SEC |
| 2026-06-04 | 4 | Statement of changes in beneficial ownership of securities | 2026-06-03 | SEC |
| 2026-05-28 | 4 | Statement of changes in beneficial ownership of securities | 2026-05-27 | SEC |
| 2026-05-28 | 4 | Statement of changes in beneficial ownership of securities | 2026-05-27 | SEC |
| 2026-05-19 | 4 | Statement of changes in beneficial ownership of securities | 2026-05-15 | SEC |
| 2026-05-19 | 4 | Statement of changes in beneficial ownership of securities | 2026-05-15 | SEC |
| 2026-05-19 | 4 | Statement of changes in beneficial ownership of securities | 2026-05-15 | SEC |
| 2026-05-15 | SCHEDULE 13G | SEC |
Insider activity by month
| Month | Bought | Buys | Sold | Sells |
|---|---|---|---|---|
| 2026-11 | 0 | 0 | 0 | 0 |
| 2026-10 | 0 | 0 | 0 | 0 |
| 2026-09 | 0 | 0 | 0 | 0 |
| 2026-08 | 0 | 0 | 0 | 0 |
| 2026-07 | 0 | 0 | 0 | 0 |
| 2026-06 | 0 | 0 | 0 | 0 |
| 2026-05 | 0 | 0 | 0 | 0 |
| 2026-04 | 0 | 0 | 0 | 0 |
| 2026-03 | 0 | 0 | 0 | 0 |
| 2026-02 | 0 | 0 | 0 | 0 |
| 2026-01 | 0 | 0 | 0 | 0 |
| 2025-12 | 0 | 0 | 399.25K | 1 |
| 2025-11 | 0 | 0 | 0 | 0 |
Institutional holders
| Manager | % owned |
|---|---|
| Polar Capital Holdings Plc | 9.67% |
| Soleus Capital Management, L.P. | 8.54% |
| First Light Asset Management, LLC | 8.39% |
| MORGAN STANLEY | 7.79% |
| BlackRock, Inc. | 7.27% |
| ORBIMED ADVISORS LLC | 4.41% |
| DRIEHAUS CAPITAL MANAGEMENT LLC | 4.25% |
| VANGUARD CAPITAL MANAGEMENT LLC | 3.60% |
| DEUTSCHE BANK AG\ | 2.73% |
| ARMISTICE CAPITAL, LLC | 2.03% |
Funds
| Fund | % owned |
|---|---|
| VANGUARD TOTAL STOCK MARKET INDEX FUND | 2.66% |
| iShares Russell 2000 ETF | 2.02% |
| VANGUARD EXTENDED MARKET INDEX FUND | 0.85% |
| Fidelity Small Cap Index Fund | 0.84% |
| iShares Russell 2000 Growth ETF | 0.73% |
| BlackRock Advantage Small Cap Core Fund | 0.66% |
| Fidelity Small Cap Growth Fund | 0.62% |
| Driehaus Micro Cap Growth Fund | 0.51% |
| VANGUARD RUSSELL 2000 INDEX FUND | 0.44% |
| Fidelity Extended Market Index Fund | 0.36% |
OakChart. NPCE. Cached 15 minutes. Terms